Toggle navigation
Home
Search
Services
Blog
Contact
About
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A.
Alexion Pharmaceuticals, Inc., Cheshire, CT, United States
Search 17 grants from Scott Rollins
Search grants from Alexion Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Targeting replication stress avoidance in cancer
Sleep disturbance, inhibition, and stress: A transdiagnostic approach to OCD
Remodeling potential of the mitral valve following surgical repair
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
Epigenetic regulation of microRNAs in neurogenesis
Recently added grants:
A SMART Design to Improve Sleep Disturbance in Adolescents with Neurodevelopmental Disorders
Functional Heterogeneity of Hypocretin Neurons
L1CAM adhesion and signaling pathways in C. elegans
Sex differences in brain injury following pediatric cardiac arrest
Congenital Myasthenic Syndromes
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL052365-03
Application #
2029136
Study Section
Special Emphasis Panel (ZRG4-HEM-2 (02))
Project Start
1994-09-30
Project End
1997-08-31
Budget Start
1996-09-05
Budget End
1997-08-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Alexion Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Cheshire
State
CT
Country
United States
Zip Code
06410
Related projects
NIH 1996
R44 HL
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A. / Alexion Pharmaceuticals, Inc.
NIH 1995
R44 HL
Complement Activation and Cardiopulmonary Bypass
Rollins, Scott A. / Alexion Pharmaceuticals, Inc.
Comments
Be the first to comment on Scott Rollins's grant